Cancer to bone: a fatal attraction

[1]  K. Pienta,et al.  Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow. , 2011, The Journal of clinical investigation.

[2]  R. Satcher,et al.  Targeting prostate cancer angiogenesis through metastasis‐associated protein 1 (MTA1) , 2011, The Prostate.

[3]  Yibin Kang,et al.  Tumor-derived JAGGED1 promotes osteolytic bone metastasis of breast cancer by engaging notch signaling in bone cells. , 2011, Cancer cell.

[4]  Laurie J. Gay,et al.  Contribution of platelets to tumour metastasis , 2011, Nature Reviews Cancer.

[5]  P. Garnero,et al.  Increased expression and serum levels of the stromal cell‐secreted protein periostin in breast cancer bone metastases , 2011, International journal of cancer.

[6]  L. Bonewald,et al.  The Amazing Osteocyte , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[7]  K. Pienta,et al.  Inhibitory Effects of Megakaryocytic Cells in Prostate Cancer Skeletal Metastasis , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[8]  W. Semmler,et al.  Sorafenib tosylate and paclitaxel induce anti-angiogenic, anti-tumour and anti-resorptive effects in experimental breast cancer bone metastases. , 2011, European journal of cancer.

[9]  J. Schneider,et al.  Integrins and bone metastasis: integrating tumor cell and stromal cell interactions. , 2011, Bone.

[10]  F. Lecanda,et al.  PDGFR signaling blockade in marrow stroma impairs lung cancer bone metastasis. , 2011, Cancer research.

[11]  Y. Fujiwara,et al.  Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  A. Jensen,et al.  The cathepsin K inhibitor odanacatib suppresses bone resorption in women with breast cancer and established bone metastases: results of a 4-week, double-blind, randomized, controlled trial. , 2010, Clinical breast cancer.

[13]  David A. Cheresh,et al.  Integrins in cancer: biological implications and therapeutic opportunities , 2010, Nature Reviews Cancer.

[14]  D. Branstetter,et al.  RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis , 2010, Nature.

[15]  J. Nyman,et al.  Inhibition of TGF‐β signaling by 1D11 antibody treatment increases bone mass and quality in vivo , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[16]  J. Vykoukal,et al.  Adipose tissue‐derived stem cells promote prostate tumor growth , 2010, The Prostate.

[17]  M. Salto‐Tellez,et al.  Cancer-related ectopic expression of the bone-related transcription factor RUNX2 in non-osseous metastatic tumor cells is linked to cell proliferation and motility , 2010, Breast Cancer Research.

[18]  R. Benezra,et al.  Using the transcription factor inhibitor of DNA binding 1 to selectively target endothelial progenitor cells offers novel strategies to inhibit tumor angiogenesis and growth. , 2010, Cancer research.

[19]  H. Dörr,et al.  Novel activating mutations of the calcium-sensing receptor: the calcilytic NPS-2143 mitigates excessive signal transduction of mutant receptors. , 2010, The Journal of clinical endocrinology and metabolism.

[20]  P. Bianco,et al.  "Mesenchymal" stem cells in human bone marrow (skeletal stem cells): a critical discussion of their nature, identity, and significance in incurable skeletal disease. , 2010, Human gene therapy.

[21]  W. Woodward,et al.  Mesenchymal Stem Cells Promote Mammosphere Formation and Decrease E-Cadherin in Normal and Malignant Breast Cells , 2010, PloS one.

[22]  Ben D. MacArthur,et al.  Mesenchymal and haematopoietic stem cells form a unique bone marrow niche , 2010, Nature.

[23]  K. Hoek,et al.  GLI2-mediated melanoma invasion and metastasis. , 2010, Journal of the National Cancer Institute.

[24]  T. Yoneda,et al.  Acid Activation of Trpv1 Leads to an Up-Regulation of Calcitonin Gene-related Peptide Expression in Dorsal Root Ganglion Neurons via the CaMK-CREB Cascade: A Potential Mechanism of Inflammatory Pain , 2010, Molecular biology of the cell.

[25]  A. Chambers,et al.  Role of the metastasis-promoting protein osteopontin in the tumour microenvironment , 2010, Journal of cellular and molecular medicine.

[26]  G. Mundy,et al.  Gr-1+CD11b+ Myeloid-Derived Suppressor Cells: Formidable Partners in Tumor Metastasis , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[27]  R. Dreicer,et al.  Zibotentan for the treatment of castrate-resistant prostate cancer , 2010, Expert opinion on investigational drugs.

[28]  J. Folkman,et al.  Platelet-derived thrombospondin-1 is a critical negative regulator and potential biomarker of angiogenesis. , 2010, Blood.

[29]  Kohei Miyazono,et al.  TGFβ signalling: a complex web in cancer progression , 2010, Nature Reviews Cancer.

[30]  D. Heymann,et al.  Interleukin‐34 is expressed by giant cell tumours of bone and plays a key role in RANKL‐induced osteoclastogenesis , 2010, The Journal of pathology.

[31]  M. Korpal,et al.  Targeting the transforming growth factor-beta signalling pathway in metastatic cancer. , 2010, European journal of cancer.

[32]  M. Ellis,et al.  Effect of zoledronic acid on disseminated tumour cells in women with locally advanced breast cancer: an open label, randomised, phase 2 trial. , 2010, The Lancet. Oncology.

[33]  M. Futakuchi,et al.  Matrix metalloproteinase (MMP)-13 regulates mammary tumor-induced osteolysis by activating MMP9 and transforming growth factor-beta signaling at the tumor-bone interface. , 2010, Cancer research.

[34]  H. Sommer,et al.  Effect of zoledronate on persisting isolated tumour cells in patients with early breast cancer. , 2010, Anticancer research.

[35]  Joshua F. McMichael,et al.  Genome Remodeling in a Basal-like Breast Cancer Metastasis and Xenograft , 2010, Nature.

[36]  F. Bauduer,et al.  Evidence of a colocalisation of osteoprotegerin (OPG) with von Willebrand factor (VWF) in platelets and megakaryocytes alpha granules. Studies from normal and grey platelets , 2010, British journal of haematology.

[37]  J. Gralow,et al.  Effects of denosumab in patients with bone metastases with and without previous bisphosphonate exposure , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[38]  M. Seibel,et al.  Vitamin D deficiency promotes human breast cancer growth in a murine model of bone metastasis. , 2010, Cancer Research.

[39]  K. Pienta,et al.  GAS6/AXL axis regulates prostate cancer invasion, proliferation, and survival in the bone marrow niche. , 2010, Neoplasia.

[40]  R. Samant,et al.  Osteopontin: an effector and an effect of tumor metastasis. , 2010, Current molecular medicine.

[41]  L. Suva,et al.  Tumor-Derived Syndecan-1 Mediates Distal Cross-Talk with Bone that Enhances Osteoclastogenesis , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[42]  G. Stein,et al.  Runx2 Association with Progression of Prostate Cancer in Patients: Mechanisms Mediating Bone Osteolysis and Osteoblastic Metastatic Lesions , 2009, Oncogene.

[43]  M. Kacena,et al.  Involvement of integrins α3β1 and α5β1 and glycoprotein IIb in megakaryocyte‐induced osteoblast proliferation , 2010, Journal of cellular biochemistry.

[44]  David A. Cheresh,et al.  Integrins in cancer: biological implications and therapeutic opportunities , 2010, Nature Reviews Cancer.

[45]  H. Takayanagi.  Osteoimmunology and the effects of the immune system on bone , 2009, Nature Reviews Rheumatology.

[46]  J. Chirgwin,et al.  Hypoxia and TGF-β Drive Breast Cancer Bone Metastases through Parallel Signaling Pathways in Tumor Cells and the Bone Microenvironment , 2009, PloS one.

[47]  G. Stein,et al.  Ectopic runx2 expression in mammary epithelial cells disrupts formation of normal acini structure: implications for breast cancer progression. , 2009, Cancer research.

[48]  Qiongqing Wang,et al.  ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis. , 2009, Genes & development.

[49]  Xin Lu,et al.  Imaging transforming growth factor-β signaling dynamics and therapeutic response in breast cancer bone metastasis , 2009, Nature Medicine.

[50]  C. Boudot,et al.  Extracellular calcium promotes the migration of breast cancer cells through the activation of the calcium sensing receptor. , 2009, Experimental cell research.

[51]  Larry Norton,et al.  Latent bone metastasis in breast cancer tied to Src-dependent survival signals. , 2009, Cancer cell.

[52]  Julie L Prior,et al.  Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100. , 2009, Blood.

[53]  Xin Lu,et al.  Efficient acquisition of dual metastasis organotropism to bone and lung through stable spontaneous fusion between MDA-MB-231 variants , 2009, Proceedings of the National Academy of Sciences.

[54]  P. Dong,et al.  Endocrine therapy plus zoledronic acid in premenopausal breast cancer. , 2009, The New England journal of medicine.

[55]  Yi Tang,et al.  TGF-β1-induced Migration of Bone Mesenchymal Stem Cells Couples Bone Resorption and Formation , 2009, Nature Medicine.

[56]  D. Piwnica-Worms,et al.  The bisphosphonate zoledronic acid decreases tumor growth in bone in mice with defective osteoclasts. , 2009, Bone.

[57]  Charles P. Lin,et al.  CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy. , 2009, Blood.

[58]  R. Ritchie,et al.  Pharmacologic Inhibition of the TGF-β Type I Receptor Kinase Has Anabolic and Anti-Catabolic Effects on Bone , 2009, PloS one.

[59]  X. Mariette,et al.  Randomized phase II trial of denosumab in patients with bone metastases from prostate cancer, breast cancer, or other neoplasms after intravenous bisphosphonates. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[60]  K. Pienta,et al.  A destructive cascade mediated by CCL2 facilitates prostate cancer growth in bone. , 2009, Cancer research.

[61]  S. Stewart,et al.  Senescent stromal-derived osteopontin promotes preneoplastic cell growth. , 2009, Cancer research.

[62]  W. Ellis,et al.  Disseminated Tumor Cells in Prostate Cancer Patients after Radical Prostatectomy and without Evidence of Disease Predicts Biochemical Recurrence , 2009, Clinical Cancer Research.

[63]  D. Link,et al.  Suppression of CXCL12 production by bone marrow osteoblasts is a common and critical pathway for cytokine-induced mobilization. , 2007, Blood.

[64]  P. Clëzardin.  Integrins in bone metastasis formation and potential therapeutic implications. , 2009, Current cancer drug targets.

[65]  D. Hume,et al.  Osteal macrophages: a new twist on coupling during bone dynamics. , 2008, Bone.

[66]  Na Zhang,et al.  Deletion of Vascular Endothelial Growth Factor in myeloid cells accelerates tumorigenesis , 2008, Nature.

[67]  Hiroyuki Aburatani,et al.  The S100A8–serum amyloid A3–TLR4 paracrine cascade establishes a pre-metastatic phase , 2008, Nature Cell Biology.

[68]  M. Colombo,et al.  Macrophage-derived SPARC bridges tumor cell-extracellular matrix interactions toward metastasis. , 2008, Cancer research.

[69]  F. Saad,et al.  Advancing Treatment for Metastatic Bone Cancer: Consensus Recommendations from the Second Cambridge Conference , 2008, Clinical Cancer Research.

[70]  L. Reynolds,et al.  Integrins: the keys to unlocking angiogenesis. , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[71]  M. Klagsbrun,et al.  Calcification of multipotent prostate tumor endothelium. , 2008, Cancer cell.

[72]  R. Mamillapalli,et al.  Switching of G-protein Usage by the Calcium-sensing Receptor Reverses Its Effect on Parathyroid Hormone-related Protein Secretion in Normal Versus Malignant Breast Cells* , 2008, Journal of Biological Chemistry.

[73]  R. Vessella,et al.  Histopathological assessment of prostate cancer bone osteoblastic metastases. , 2008, The Journal of urology.

[74]  Evan T. Keller,et al.  Type I collagen receptor (α2β1) signaling promotes prostate cancer invasion through RhoC GTPase , 2008 .

[75]  Hiroki Wakabayashi,et al.  Decorin Suppresses Bone Metastasis in a Breast Cancer Cell Line , 2008, Oncology.

[76]  F. Marshall,et al.  Receptor activator of NF-κB Ligand (RANKL) expression is associated with epithelial to mesenchymal transition in human prostate cancer cells , 2008, Cell Research.

[77]  E. Keller,et al.  Prostate cancer induces bone metastasis through Wnt-induced bone morphogenetic protein-dependent and independent mechanisms. , 2008, Cancer research.

[78]  F. Saad,et al.  Normalization of bone markers is associated with improved survival in patients with bone metastases from solid tumors and elevated bone resorption receiving zoledronic acid , 2008, Cancer.

[79]  E. Morgan,et al.  APT102, a novel adpase, cooperates with aspirin to disrupt bone metastasis in mice , 2008, Journal of cellular biochemistry.

[80]  R. Weinberg,et al.  Systemic Endocrine Instigation of Indolent Tumor Growth Requires Osteopontin , 2008, Cell.

[81]  I. Weissman,et al.  Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth , 2008, Proceedings of the National Academy of Sciences.

[82]  A. Chakraborty,et al.  Fusion of tumour cells with bone marrow-derived cells: a unifying explanation for metastasis , 2008, Nature Reviews Cancer.

[83]  A. Teti,et al.  Inhibition of protein kinase c-Src as a therapeutic approach for cancer and bone metastases. , 2008, Anti-cancer agents in medicinal chemistry.

[84]  W. Zou,et al.  RelB is the NF-κB subunit downstream of NIK responsible for osteoclast differentiation , 2008, Proceedings of the National Academy of Sciences.

[85]  V. Castronovo,et al.  Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer , 2008, Nature Reviews Cancer.

[86]  D. Nolan,et al.  Endothelial Progenitor Cells Control the Angiogenic Switch in Mouse Lung Metastasis , 2008, Science.

[87]  P. Frankel,et al.  Biologic Markers of Angiogenesis: Circulating Endothelial Cells in Patients with Advanced Malignancies Treated on Phase I Protocol with Metronomic Chemotherapy and Celecoxib , 2008, Cancer investigation.

[88]  L. Reynolds,et al.  The Keys to Unlocking Angiogenesis , 2008 .

[89]  J. Chirgwin,et al.  Molecular biology of bone metastasis. , 2008, Molecular cancer therapeutics.

[90]  Z. Werb,et al.  Amino-biphosphonate-mediated MMP-9 inhibition breaks the tumor-bone marrow axis responsible for myeloid-derived suppressor cell expansion and macrophage infiltration in tumor stroma. , 2007, Cancer research.

[91]  G. Prud’homme.  Pathobiology of transforming growth factor β in cancer, fibrosis and immunologic disease, and therapeutic considerations , 2007, Laboratory Investigation.

[92]  F. Journé,et al.  Increased Dickkopf-1 expression in breast cancer bone metastases , 2007, British Journal of Cancer.

[93]  S. Vukicevic,et al.  Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer. , 2007, Cancer research.

[94]  Antoinette Wetterwald,et al.  BMP7, a putative regulator of epithelial homeostasis in the human prostate, is a potent inhibitor of prostate cancer bone metastasis in vivo. , 2007, The American journal of pathology.

[95]  L. Ylagan,et al.  Isolation and Molecular Profiling of Bone Marrow Micrometastases Identifies TWIST1 as a Marker of Early Tumor Relapse in Breast Cancer Patients , 2007, Clinical Cancer Research.

[96]  E. Morgan,et al.  Disruption of CXCR4 enhances osteoclastogenesis and tumor growth in bone , 2007, Proceedings of the National Academy of Sciences.

[97]  G. Donofrio,et al.  Production of Wnt inhibitors by myeloma cells: potential effects on canonical Wnt pathway in the bone microenvironment. , 2007, Cancer research.

[98]  R. Zellweger,et al.  BONE MORPHOGENETIC PROTEINS IN CLINICAL APPLICATIONS , 2007, ANZ journal of surgery.

[99]  Weilin Zhou,et al.  Platelet-activating factor induces ovine fetal pulmonary venous smooth muscle cell proliferation: role of epidermal growth factor receptor transactivation. , 2007, American journal of physiology. Heart and circulatory physiology.

[100]  T. Yoneda,et al.  Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer. , 2007, Cancer research.

[101]  K. Trinkaus,et al.  Granulocyte colony-stimulating factor enhances bone tumor growth in mice in an osteoclast-dependent manner. , 2007, Blood.

[102]  K. Mohammad,et al.  Stable overexpression of Smad7 in human melanoma cells impairs bone metastasis. , 2007, Cancer research.

[103]  O. Stephens,et al.  Dickkopf homolog 1 mediates endothelin-1-stimulated new bone formation. , 2007, Molecular endocrinology.

[104]  T. Plesner,et al.  Osteoclast nuclei of myeloma patients show chromosome translocations specific for the myeloma cell clone: a new type of cancer–host partnership? , 2007, The Journal of pathology.

[105]  K. Pienta,et al.  Expression and activation of αvβ3 integrins by SDF‐1/CXC12 increases the aggressiveness of prostate cancer cells , 2007 .

[106]  T. Giordano,et al.  NF-κB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF , 2007, Nature Medicine.

[107]  M. Colombo,et al.  The terminology issue for myeloid-derived suppressor cells. , 2007, Cancer research.

[108]  V. Castronovo,et al.  Low dentin matrix protein 1 expression correlates with skeletal metastases development in breast cancer patients and enhances cell migratory capacity in vitro , 2007, Breast Cancer Research and Treatment.

[109]  M. Rogers,et al.  Molecular Cancer Mechanisms of Osteopontin and Cd44 as Metastatic Principles in Prostate Cancer Cells , 2006 .

[110]  A. Griffioen,et al.  Monocyte/macrophage infiltration in tumors: modulators of angiogenesis , 2006, Journal of leukocyte biology.

[111]  Y. Kadono,et al.  Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction , 2006, The Journal of experimental medicine.

[112]  J. Compston,et al.  Osteoclast formation and bone resorption are inhibited by megakaryocytes. , 2006, Bone.

[113]  Robert D. Schreiber,et al.  Interferons, immunity and cancer immunoediting , 2006, Nature Reviews Immunology.

[114]  E. Morgan,et al.  Skeletal Complications of Breast Cancer Therapies , 2006, Clinical Cancer Research.

[115]  A. Jimeno,et al.  Targeting Bone Metastasis in Prostate Cancer with Endothelin Receptor Antagonists , 2006, Clinical Cancer Research.

[116]  J. Chirgwin,et al.  Basic Mechanisms Responsible for Osteolytic and Osteoblastic Bone Metastases , 2006, Clinical Cancer Research.

[117]  D. Clohisy,et al.  Biology of Bone Cancer Pain , 2006, Clinical Cancer Research.

[118]  A. Schneider,et al.  Extracellular calcium as a candidate mediator of prostate cancer skeletal metastasis. , 2006, Cancer research.

[119]  E. Keller,et al.  Type I Collagen Receptor (α2β1) Signaling Promotes the Growth of Human Prostate Cancer Cells within the Bone , 2006 .

[120]  L. Naldini,et al.  Role of haematopoietic cells and endothelial progenitors in tumour angiogenesis. , 2006, Biochimica et biophysica acta.

[121]  Ming Zhao,et al.  The hedgehog signaling molecule Gli2 induces parathyroid hormone-related peptide expression and osteolysis in metastatic human breast cancer cells. , 2006, Cancer research.

[122]  Ari Elson,et al.  Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells , 2006, Nature Medicine.

[123]  O. MacDougald,et al.  Role of wnts in prostate cancer bone metastases , 2006, Journal of cellular biochemistry.

[124]  V. Castronovo,et al.  Expression of dentin sialophosphoprotein in human prostate cancer and its correlation with tumor aggressiveness , 2006, International journal of cancer.

[125]  J. Hopper,et al.  Parathyroid hormone-related protein localization in breast cancers predict improved prognosis. , 2006, Cancer research.

[126]  Xiyun Deng,et al.  CXCL12/CXCR4 signaling activates Akt‐1 and MMP‐9 expression in prostate cancer cells: The role of bone microenvironment‐associated CXCL12 , 2006, The Prostate.

[127]  L. Ratner,et al.  HTLV-1 Tax transgenic mice develop spontaneous osteolytic bone metastases prevented by osteoclast inhibition. , 2005, Blood.

[128]  S. Rafii,et al.  VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche , 2005, Nature.

[129]  Toshio Matsumoto,et al.  Myeloma cells suppress bone formation by secreting a soluble Wnt inhibitor, sFRP-2. , 2005, Blood.

[130]  Wei He,et al.  Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[131]  Yi Lu,et al.  Bone morphogenetic protein-6 promotes osteoblastic prostate cancer bone metastases through a dual mechanism. , 2005, Cancer research.

[132]  G. Karsenty,et al.  Cooperative Interactions between Activating Transcription Factor 4 and Runx2/Cbfa1 Stimulate Osteoblast-specific Osteocalcin Gene Expression* , 2005, Journal of Biological Chemistry.

[133]  F. Saad,et al.  Predictive value of bone resorption and formation markers in cancer patients with bone metastases receiving the bisphosphonate zoledronic acid. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[134]  L. Suva,et al.  Expression of heparanase by primary breast tumors promotes bone resorption in the absence of detectable bone metastases. , 2005, Cancer research.

[135]  Y. Ko,et al.  Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size , 2005, The Journal of experimental medicine.

[136]  Dennis C. Sgroi,et al.  Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion , 2005, Cell.

[137]  Tomoyuki Shirai,et al.  MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL. , 2005, Cancer cell.

[138]  A. Vignery.  Macrophage fusion: are somatic and cancer cells possible partners? , 2005, Trends in cell biology.

[139]  K. Pienta,et al.  Bone turnover mediates preferential localization of prostate cancer in the skeleton. , 2005, Endocrinology.

[140]  G. Stein,et al.  Impaired intranuclear trafficking of Runx2 (AML3/CBFA1) transcription factors in breast cancer cells inhibits osteolysis in vivo. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[141]  Abraham Schneider,et al.  Skeletal Localization and Neutralization of the SDF‐1(CXCL12)/CXCR4 Axis Blocks Prostate Cancer Metastasis and Growth in Osseous Sites In Vivo , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[142]  M. Kitajima,et al.  The Relationship Between Bone Metastasis from Human Breast Cancer and Integrin αvβ3 Expression , 2005 .

[143]  R. Ritchie,et al.  TGF-regulates the mechanical properties and composition of bone matrix , 2005 .

[144]  A. Yang,et al.  CXCR4 knockdown by small interfering RNA abrogates breast tumor growth in vivo , 2005, Cancer Gene Therapy.

[145]  P. Clézardin,et al.  Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer. , 2004, The Journal of clinical investigation.

[146]  U. Choi,et al.  CXCR4‐Transgene Expression Significantly Improves Marrow Engraftment of Cultured Hematopoietic Stem Cells , 2004, Stem cells.

[147]  D. Piwnica-Worms,et al.  CXCR4 Regulates Growth of Both Primary and Metastatic Breast Cancer , 2004, Cancer Research.

[148]  G. Karsenty,et al.  ATF4, the Osteoblast Accumulation of Which Is Determined Post-translationally, Can Induce Osteoblast-specific Gene Expression in Non-osteoblastic Cells* , 2004, Journal of Biological Chemistry.

[149]  M. Andreeff,et al.  Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. , 2004, Journal of the National Cancer Institute.

[150]  K. Moriyama,et al.  Osteoclasts enhance myeloma cell growth and survival via cell-cell contact: a vicious cycle between bone destruction and myeloma expansion. , 2004, Blood.

[151]  Paul J. Williams,et al.  Anti-alpha4 integrin antibody suppresses the development of multiple myeloma and associated osteoclastic osteolysis. , 2004, Blood.

[152]  E. Brown,et al.  Calcium-sensing receptor activation stimulates parathyroid hormone-related protein secretion in prostate cancer cells: role of epidermal growth factor receptor transactivation. , 2004, Bone.

[153]  P. Frenette,et al.  The integrin αMβ2 anchors hematopoietic progenitors in the bone marrow during enforced mobilization , 2004 .

[154]  R. Korah,et al.  Integrin α5β1 Promotes Survival of Growth-Arrested Breast Cancer Cells , 2004, Cancer Research.

[155]  P. Sassone-Corsi,et al.  ATF4 Is a Substrate of RSK2 and an Essential Regulator of Osteoblast Biology Implication for Coffin-Lowry Syndrome , 2004, Cell.

[156]  G. Roodman.  Mechanisms of bone metastasis. , 2004, Discovery medicine.

[157]  S. Karlsson,et al.  Overexpression of CXCR4 on human CD34+ progenitors increases their proliferation, migration, and NOD/SCID repopulation. , 2004, Blood.

[158]  Andrés Hidalgo,et al.  Integrin α4β1 involvement in stromal cell-derived factor-1α-promoted myeloma cell transendothelial migration and adhesion: role of cAMP and the actin cytoskeleton in adhesion , 2004 .

[159]  J. Platt,et al.  Melanoma × macrophage hybrids with enhanced metastatic potential , 1998, Clinical & Experimental Metastasis.

[160]  N. Clarke,et al.  Primary prostatic epithelial cell binding to human bone marrow stroma and the role of a2b1 integrin , 1997, Clinical & Experimental Metastasis.

[161]  R. Korah,et al.  Integrin alpha5beta1 promotes survival of growth-arrested breast cancer cells: an in vitro paradigm for breast cancer dormancy in bone marrow. , 2004, Cancer research.

[162]  M. Waltham,et al.  Transfection of MDA-MB-231 human breast carcinoma cells with bone sialoprotein (BSP) stimulates migration and invasion in vitro and growth of primary and secondary tumors in nude mice , 2004, Clinical & Experimental Metastasis.

[163]  Daphne Vassiliou,et al.  Differential expression of osteopontin and bone sialoprotein in bone metastasis of breast and prostate carcinoma , 2004, Clinical & Experimental Metastasis.

[164]  F. Zhan,et al.  The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma. , 2003, The New England journal of medicine.

[165]  N. Harbeck,et al.  Detection and clinical implications of early systemic tumor cell dissemination in breast cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[166]  M. Rogers.  New insights into the molecular mechanisms of action of bisphosphonates. , 2003, Current pharmaceutical design.

[167]  P. Clézardin,et al.  Angiostatin Inhibits Bone Metastasis Formation in Nude Mice through a Direct Anti-osteoclastic Activity* , 2003, Journal of Biological Chemistry.

[168]  M. Tomasson,et al.  Platelet and osteoclast β3 integrins are critical for bone metastasis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[169]  D. Scadden,et al.  Osteoblastic cells regulate the haematopoietic stem cell niche , 2003, Nature.

[170]  Haiyang Huang,et al.  Identification of the haematopoietic stem cell niche and control of the niche size , 2003, Nature.

[171]  J. Chirgwin,et al.  A causal role for endothelin-1 in the pathogenesis of osteoblastic bone metastases , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[172]  S. Teitelbaum,et al.  Genetic regulation of osteoclast development and function , 2003, Nature Reviews Genetics.

[173]  R. Vessella,et al.  Prostate cancer expression of runt‐domain transcription factor Runx2, a key regulator of osteoblast differentiation and function , 2003, The Prostate.

[174]  C. Cordon-Cardo,et al.  A multigenic program mediating breast cancer metastasis to bone. , 2003, Cancer cell.

[175]  K. Pienta,et al.  Expression of CXCR4 and CXCL12 (SDF‐1) in human prostate cancers (PCa) in vivo , 2003, Journal of cellular biochemistry.

[176]  K. Pienta,et al.  Stromal factors involved in prostate carcinoma metastasis to bone , 2003, Cancer.

[177]  G. Mundy.  Metastasis: Metastasis to bone: causes, consequences and therapeutic opportunities , 2002, Nature Reviews Cancer.

[178]  Noam Brown,et al.  The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapies , 2002, The Journal of pathology.

[179]  J. Deng,et al.  The Novel Zinc Finger-Containing Transcription Factor Osterix Is Required for Osteoblast Differentiation and Bone Formation , 2002, Cell.

[180]  I. Holen,et al.  Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma. , 2001, Blood.

[181]  Flemming Melsen,et al.  Cancellous Bone Remodeling Occurs in Specialized Compartments Lined by Cells Expressing Osteoblastic Markers , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[182]  L. Radbruch,et al.  Symptoms during cancer pain treatment following WHO-guidelines: a longitudinal follow-up study of symptom prevalence, severity and etiology , 2001, Pain.

[183]  H. Iguchi,et al.  Increased incidence of bone metastases in hepatocellular carcinoma , 2001, European journal of gastroenterology & hepatology.

[184]  R. Coleman.  Metastatic bone disease: clinical features, pathophysiology and treatment strategies. , 2001, Cancer treatment reviews.

[185]  M. Noda,et al.  Osteopontin Deficiency Reduces Experimental Tumor Cell Metastasis to Bone and Soft Tissues , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[186]  T. Mcclanahan,et al.  Involvement of chemokine receptors in breast cancer metastasis , 2001, Nature.

[187]  E. Brown,et al.  Expression of extracellular calcium-sensing receptor in human osteoblastic MG-63 cell line. , 2001, American journal of physiology. Cell physiology.

[188]  E. Brown,et al.  Extracellular calcium-sensing receptor expression and its potential role in regulating parathyroid hormone-related peptide secretion in human breast cancer cell lines. , 2000, Endocrinology.

[189]  Paul J. Williams,et al.  Cell–cell contact between marrow stromal cells and myeloma cells via VCAM-1 and α4β1-integrin enhances production of osteoclast-stimulating activity , 2000 .

[190]  P Delmas,et al.  Bisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastases. , 2000, Cancer research.

[191]  P. Mantyh,et al.  Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord , 2000, Nature Medicine.

[192]  A. McEwan,et al.  Use of radionuclides for the palliation of bone metastases. , 2000, Seminars in radiation oncology.

[193]  T. Dimpfl,et al.  Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. , 2000, The New England journal of medicine.

[194]  H Sommer,et al.  Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[195]  T. Papayannopoulou,et al.  Mechanisms of stem-/progenitor-cell mobilization: the anti-VLA-4 paradigm. , 2000, Seminars in hematology.

[196]  T. Yoneda.  Cellular and molecular basis of preferential metastasis of breast cancer to bone , 2000, Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association.

[197]  W. Dougall,et al.  RANK is essential for osteoclast and lymph node development. , 1999, Genes & development.

[198]  L. Chung,et al.  Osteomimetic properties of prostate cancer cells: A hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment , 1999, The Prostate.

[199]  T. Martin,et al.  Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. , 1999, Endocrine reviews.

[200]  W. Dalton,et al.  Cell Adhesion Mediated Drug Resistance (CAM-DR): Role of Integrins and Resistance to Apoptosis in Human Myeloma Cell Lines , 1999 .

[201]  R Wieser,et al.  TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. , 1999, The Journal of clinical investigation.

[202]  A. Sundan,et al.  Hepatocyte growth factor (HGF) induces interleukin-11 secretion from osteoblasts: a possible role for HGF in myeloma-associated osteolytic bone disease. , 1999, Blood.

[203]  W. Dalton,et al.  Cell adhesion mediated drug resistance (CAM-DR): role of integrins and resistance to apoptosis in human myeloma cell lines. , 1999, Blood.

[204]  K. Luzzi,et al.  Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. , 1998, The American journal of pathology.

[205]  K. Pienta,et al.  Preferential adhesion of prostate cancer cells to a human bone marrow endothelial cell line. , 1998, Journal of the National Cancer Institute.

[206]  S. Braun,et al.  Re: Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status. , 1996, Journal of the National Cancer Institute.

[207]  Makoto Sato,et al.  Targeted Disruption of Cbfa1 Results in a Complete Lack of Bone Formation owing to Maturational Arrest of Osteoblasts , 1997, Cell.

[208]  B F Boyce,et al.  Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis. , 1996, The Journal of clinical investigation.

[209]  Y. Takada,et al.  Induction of experimental bone metastasis in mice by transfection of integrin α4β1 into tumor cells , 1996 .

[210]  R. Holle,et al.  Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status. , 1996, Journal of the National Cancer Institute.

[211]  J. Nelson,et al.  Identification of endothelin–1 in the pathophysiology of metastatic adenocarcinoma of the prostate , 1995, Nature Medicine.

[212]  P. Allavena,et al.  Effects of granulocyte‐monocyte colony‐stimulating factor (GM‐CSF) on expression of adhesion molecules and production of cytokines in blood monocytes and ovarian cancer‐associated macrophages , 1995, International journal of cancer.

[213]  J. Dipersio,et al.  Integrins and adhesive receptors in normal and leukemic CD34+ progenitor cells: potential regulatory checkpoints for cellular traffic. , 1994, Leukemia & lymphoma.

[214]  M. Gleave,et al.  Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts. , 1991, Cancer research.

[215]  N. Clarke,et al.  Morphometric evidence for bone resorption and replacement in prostate cancer. , 1991, British journal of urology.

[216]  B. Zetter,et al.  Stimulation of human prostatic carcinoma cell growth by factors present in human bone marrow. , 1989, The Journal of clinical investigation.

[217]  I. Fidler,et al.  Metastasis: Quantitative Analysis of Distribution and Fate of Tumor Emboli Labeled With 125I-5-Iodo-2′ -deoxyuridine , 1970 .

[218]  E. Butt,et al.  Palindromic unilateral renal purpura: an explanation for renal hematuria of obscure origin. , 1952, Transactions. American Urological Association. Western Section.

[219]  Y. Oshika,et al.  P-glycoprotein-mediated acquired multidrug resistance of human lung cancer cells in vivo. , 1996, British Journal of Cancer.